IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 208 filers reported holding IMMUNOMEDICS INC in Q2 2019. The put-call ratio across all filers is 0.19 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $54,000 | +134.8% | 630 | -1.6% | 0.03% | +125.0% |
Q2 2020 | $23,000 | +155.6% | 640 | 0.0% | 0.01% | +100.0% |
Q1 2020 | $9,000 | -35.7% | 640 | 0.0% | 0.01% | -25.0% |
Q4 2019 | $14,000 | +75.0% | 640 | 0.0% | 0.01% | +60.0% |
Q3 2019 | $8,000 | -11.1% | 640 | +1.6% | 0.01% | 0.0% |
Q2 2019 | $9,000 | -25.0% | 630 | 0.0% | 0.01% | -37.5% |
Q1 2019 | $12,000 | +33.3% | 630 | 0.0% | 0.01% | +33.3% |
Q4 2018 | $9,000 | -30.8% | 630 | 0.0% | 0.01% | -33.3% |
Q3 2018 | $13,000 | -13.3% | 630 | 0.0% | 0.01% | -18.2% |
Q2 2018 | $15,000 | +66.7% | 630 | 0.0% | 0.01% | +57.1% |
Q1 2018 | $9,000 | – | 630 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACUTA CAPITAL PARTNERS, LLC | 1,711,067 | $2,943,000 | 1.70% |
J.P. Turner & Co Capital Mnagement, LLC | 248,625 | $428,000 | 0.44% |
Orbimed Advisors | 3,323,000 | $5,716,000 | 0.06% |
BALYASNY ASSET MANAGEMENT L.P. | 2,004,078 | $3,447,000 | 0.02% |
WOLVERINE ASSET MANAGEMENT LLC | 5,870 | $1,018,000 | 0.02% |
SIGNET FINANCIAL MANAGEMENT, LLC | 44,675 | $77,000 | 0.02% |
SVB WEALTH LLC | 195,000 | $335,000 | 0.01% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 288,900 | $497,000 | 0.01% |
J.P. Turner & Co Capital Mnagement, LLC | 153,900 | $8,000 | 0.01% |
BALYASNY ASSET MANAGEMENT L.P. | 640,400 | $1,101,000 | 0.01% |